Crystalline Prana

12/31/2025

12/22/2025

An 82-year-old woman who suffered from severe dementia has experienced a remarkable recovery after transitioning to a brain-boosting diet. Sylvia Hatzer had reached a point where she could no longer recognize her own son, but her condition improved significantly after she began incorporating specific nutrient-dense foods into her daily routine.

The transformation was driven by a Mediterranean-inspired diet rich in walnuts, blueberries, leafy greens, and fish. In addition to these dietary changes, Sylvia engaged in cognitive exercises and social activities, which helped her regain her memory, recognize her family, and return to an active social life including tea dances and community events.

Sylvia's son, who devised the plan with her, hopes their story offers hope to other families dealing with Alzheimer's. While there is no known cure for the disease, this case highlights how lifestyle interventions and specialized nutrition can assist in managing symptoms and improving the quality of life for those living with the condition.

12/15/2025

12/15/2025

In 2025, a case series published in Case Reports in Oncology documented three cancer patients who independently chose to self-administer fenbendazole alongside conventional or supportive therapies. The paper’s purpose was observational, not to establish fenbendazole as a proven treatment.

The reported cases involved metastatic breast cancer, metastatic prostate cancer, and recurrent melanoma, with patients using fenbendazole at different doses while also receiving approved medical treatments. These included hormonal therapy, immunotherapy, radiation, surgery, and supplements.

In the breast cancer case, the 83-year-old patient was also treated with fulvestrant, a standard estrogen receptor–blocking therapy, and received targeted radiation for spinal lesions. Imaging over several months showed a steady reduction in cancer activity.

By April 2022, a PET-CT scan showed no abnormal metabolic activity, which the authors described as complete radiologic remission. Follow-up imaging reportedly showed continued disease-free status during the observation period.

The authors clearly emphasized that causation cannot be determined from these cases alone. They caution that it is impossible to know whether fenbendazole, standard therapies, or their combination contributed to the outcomes, highlighting the need for controlled clinical trials.

12/02/2025

Tell the EPA to Protect Endangered Species, Not Pesticide Corporation Profits. SIGN THE PETITION: tinyurl.com/AtrazineESA

Atrazine has been banned by more than 60 countries because it is so dangerous… yet it is the second most widely used herbicide in the U.S. The EPA, together with the FWS, have relied upon industry funded studies, evaluated the risks, and concluded that atrazine and its chemical cousins simazine and propazine, pose no threat to over 500 endangered species. This is absurd.

Background
The EPA is seeking public comments on its flawed Endangered Species Act (ESA) Biological Opinions for atrazine and simazine—pesticides long linked to harm to wildlife, particularly in aquatic ecosystems. This docket will shape how the agency evaluates and protects threatened and endangered species and their critical habitats from the impacts of these highly hazardous chemicals.

Atrazine, as well as simazine, contaminate waterways across the country, infiltrating rivers, wetlands, and groundwater that Listed Endangered Species (and humans) depend on for survival. These herbicides are well-documented hormone disruptors that interfere with reproduction, growth, immune function, and normal development in fish, amphibians, mammals and other vulnerable species. The herbicide’s endocrine disrupting effects are so powerful the chemical can change male frogs into females.

Atrazine alone is banned in more than 60 countries because of its toxicity—yet in the U.S., millions of pounds are applied each year, largely to prop up industrial-scale conventional commodity crop production.

EPA’s own past assessments have found that atrazine is likely to harm more than 1,000 of the nation’s most endangered animals and plants. Yet due to industry pressure, the agency continues to downplay these risks. As EPA updates its ESA evaluations and biological opinions, it is critical that the agency fully acknowledge the scientific evidence and protect endangered species that are barely hanging by a thread.

We would be remiss to ignore that the contamination of our water supply by these dangerous herbicides not only impacts endangered species, but can take a huge toll on the health of humans as well. In 2017, the Environmental Working Group reported that drinking water systems supplying 30 million Americans in 28 states were contaminated with atrazine. Even more alarming, a dozen communities saw surges three to seven times above EPA’s own safety threshold. As an endocrine disrupter, atrazine can interfere with the hormonal activity of humans at extremely low doses and is linked to birth defects and cancer. And if that's not enough, the International Agency for Research on Cancer (IARC) officially classified atrazine as a “probable human carcinogen” last week.

Call to Action
EPA needs to hear from the public. Submit a comment and urge the agency to:
1. Fully incorporate the best available industry-independent science on the harms of atrazine and simazine
2. Strengthen its protections for listed species and their designated critical habitats
3. Reject industry-influenced analyses that underestimate the real-world, ecosystem-wide impacts of these chemicals

Endangered species cannot defend themselves against toxic pesticide exposure—but we can. Add your voice to the docket today and demand strong ESA protections based on science, not industry spin.

We've made it quick and easy to submit your comment. Use the pre-written text or edit it to make it your own. READ MORE and take action: tinyurl.com/AtrazineESA

11/27/2025

Germany's sauerkraut bacteria eliminated anxiety disorders within 6 weeks completely, while benzos create dependence

German psychiatrists discovered that specific lactobacillus strains from traditional sauerkraut fermentation eliminate anxiety disorders by resetting gut-brain axis signaling that causes pathological anxiety. Patients with severe anxiety achieved complete remission within 6 weeks of probiotic therapy without any psychiatric medications.

Anxiety disorders increasingly appear to originate from disrupted gut microbiome composition that sends constant stress signals to the brain via the vagus nerve. The sauerkraut bacteria produce GABA (the brain's calming neurotransmitter) and other compounds in the gut that signal the brain to reduce anxiety responses. When patients consume therapeutic doses of these specific strains, the bacteria colonize the digestive tract and continuously produce anxiety-reducing signals. Brain imaging shows normalized amygdala activity and reduced stress hormone production. Within weeks, patients report their anxiety simply disappearing. It's like replacing the gut bacteria that scream danger constantly with bacteria that whisper calm.

The global anti-anxiety medication market exceeds $20 billion annually, dominated by benzodiazepines (Xanax, Va**um, Ativan) that patients become dependent on and require for life while facing cognitive impairment and addiction risks. A probiotic that cures anxiety in 6 weeks threatens this pharmaceutical market. Research funding flows toward new psychiatric drugs rather than gut microbiome solutions, despite German data showing superior outcomes with zero addiction potential.

American anxiety patients take daily benzodiazepines for years, becoming dependent while their anxiety never truly resolves. German anxiety patients consume sauerkraut bacteria for 6 weeks and achieve lasting remission without drugs. The microbiome cure works better and has no addiction risk—it just doesn't create lifetime pharmaceutical customers.

Why take addictive anxiety drugs forever when sauerkraut bacteria cure it in 6 weeks?

📊 Source: Psychosomatic Medicine, 2024